** Jefferies starts coverage on Australia's HealthCo
Healthcare and Wellness REIT HCW.AX , rates stock "hold"
** Brokerage says HCW offers access to a growing portfolio
of quality healthcare and wellness assets, gives the stock a PT
of A$1.80
** Jefferies says HCW showed a strong track record of
execution over a short time period in a highly fragmented market
** Sees increased life sciences demand associated with
increased R&D across stem cell research, to be a big source of
growth for co's assets
** Says HCW offers investors exposure to a ~A$765 mln
($516.22 mln) portfolio of private hospitals and medical hubs
** Adds co's leases provide inflation protection with
further growth from developments
** Three of five analysts rate the stock "buy" , two "hold"
; their median PT is A$1.80 – Refinitiv data
** Stock had fallen 23.4% this year, as of last close
($1 = 1.4819 Australian dollars)
(Reporting by Nausheen Thusoo in Bengaluru)
((Nausheen.Thusoo@thomsonreuters.com;))